Shenzhen Weiguang Biological Products Co., Ltd.

SZSE:002880 Stock Report

Market Cap: CN¥6.4b

Shenzhen Weiguang Biological Products Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Caiping Guo

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.3yrs
CEO ownershipn/a
Management average tenure22.8yrs
Board average tenure5.9yrs

Recent management updates

Recent updates

CEO

Caiping Guo (53 yo)

3.3yrs

Tenure

CN¥1,268,300

Compensation

Ms. Caiping Guo is GM & Director of Shenzhen Weiguang Biological Products Co., Ltd. from December 09, 2021. She was General manager of Shenzhen Weiguang Biological Products Co., Ltd.from September 29, 202...

Leadership Team

NamePositionTenureCompensationOwnership
Caiping Guo
GM & Director3.3yrsCN¥1.27mno data
Qiang Xu
Deputy General Manager22.8yrsCN¥1.08mno data
Xin Zhang
Deputy GM24.5yrsCN¥1.08mno data

22.8yrs

Average Tenure

60yo

Average Age

Experienced Management: 002880's management team is seasoned and experienced (22.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Caiping Guo
GM & Director3yrsCN¥1.27mno data
Xin Zhang
Deputy GM3yrsCN¥1.08mno data
Xinfa Yang
Independent Director5.9yrsCN¥50.00kno data
Zhan Zhang
Chairman of the Boardno dataCN¥1.08mno data
Xinmin Wang
Independent Director5.9yrsCN¥50.00kno data
Peng Geng
Supervisor5.9yrsno datano data

5.9yrs

Average Tenure

54yo

Average Age

Experienced Board: 002880's board of directors are considered experienced (5.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 12:03
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen Weiguang Biological Products Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kai WangCitic Securities Co., Ltd.
Xiao Wei LinEverbright Securities Co. Ltd.